Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: MAP's Levadex Ready For FDA Approval

"Importantly, clinical studies indicate Levadex may not have the same level of pulmonary side effects as other aerosolized medications, such as Alexza Pharmaceuticals' (ALXA) Adasuve and MannKind Corporation's (MNKD) Afrezza."

http://seekingalpha.com/article/1152371-map-s-levadex-ready-for-fda-approval?source=google_news

Share
New Message
Please login to post a reply